Literature DB >> 27579860

Macrophage-mediated gliadin degradation and concomitant IL-27 production drive IL-10- and IFN-γ-secreting Tr1-like-cell differentiation in a murine model for gluten tolerance.

M A van Leeuwen1, L M M Costes1, L A van Berkel1, Y Simons-Oosterhuis1, M F du Pré1,2, A E Kozijn1, H C Raatgeep1, D J Lindenbergh-Kortleve1, N van Rooijen3, F Koning4, J N Samsom1.   

Abstract

Celiac disease is caused by inflammatory T-cell responses against the insoluble dietary protein gliadin. We have shown that, in humanized mice, oral tolerance to deamidated chymotrypsin-digested gliadin (CT-TG2-gliadin) is driven by tolerogenic interferon (IFN)-γ- and interleukin (IL)-10-secreting type 1 regulatory T-like cells (Tr1-like cells) generated in the spleen but not in the mesenteric lymph nodes. We aimed to uncover the mechanisms underlying gliadin-specific Tr1-like-cell differentiation and hypothesized that proteolytic gliadin degradation by splenic macrophages is a decisive step in this process. In vivo depletion of macrophages caused reduced differentiation of splenic IFN-γ- and IL-10-producing Tr1-like cells after CT-TG2-gliadin but not gliadin peptide feed. Splenic macrophages, rather than dendritic cells, constitutively expressed increased mRNA levels of the endopeptidase Cathepsin D; macrophage depletion significantly reduced splenic Cathepsin D expression in vivo and Cathepsin D efficiently degraded recombinant γ-gliadin in vitro. In response to CT-TG2-gliadin uptake, macrophages enhanced the expression of Il27p28, a cytokine that favored differentiation of gliadin-specific Tr1-like cells in vitro, and was previously reported to increase Cathepsin D activity. Conversely, IL-27 neutralization in vivo inhibited splenic IFN-γ- and IL-10-secreting Tr1-like-cell differentiation after CT-TG2-gliadin feed. Our data infer that endopeptidase mediated gliadin degradation by macrophages and concomitant IL-27 production drive differentiation of splenic gliadin-specific Tr1-like cells.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27579860     DOI: 10.1038/mi.2016.76

Source DB:  PubMed          Journal:  Mucosal Immunol        ISSN: 1933-0219            Impact factor:   7.313


  5 in total

1.  Reovirus infection triggers inflammatory responses to dietary antigens and development of celiac disease.

Authors:  Romain Bouziat; Reinhard Hinterleitner; Judy J Brown; Jennifer E Stencel-Baerenwald; Mine Ikizler; Toufic Mayassi; Marlies Meisel; Sangman M Kim; Valentina Discepolo; Andrea J Pruijssers; Jordan D Ernest; Jason A Iskarpatyoti; Léa M M Costes; Ian Lawrence; Brad A Palanski; Mukund Varma; Matthew A Zurenski; Solomiia Khomandiak; Nicole McAllister; Pavithra Aravamudhan; Karl W Boehme; Fengling Hu; Janneke N Samsom; Hans-Christian Reinecker; Sonia S Kupfer; Stefano Guandalini; Carol E Semrad; Valérie Abadie; Chaitan Khosla; Luis B Barreiro; Ramnik J Xavier; Aylwin Ng; Terence S Dermody; Bana Jabri
Journal:  Science       Date:  2017-04-07       Impact factor: 47.728

Review 2.  Role of orally induced regulatory T cells in immunotherapy and tolerance.

Authors:  Thais B Bertolini; Moanaro Biswas; Cox Terhorst; Henry Daniell; Roland W Herzog; Annie R Piñeros
Journal:  Cell Immunol       Date:  2020-11-14       Impact factor: 4.868

3.  A B-Cell Gene Signature Correlates With the Extent of Gluten-Induced Intestinal Injury in Celiac Disease.

Authors:  Mitchell E Garber; Alok Saldanha; Joel S Parker; Wendell D Jones; Katri Kaukinen; Kaija Laurila; Marja-Leena Lähdeaho; Purvesh Khatri; Chaitan Khosla; Daniel C Adelman; Markku Mäki
Journal:  Cell Mol Gastroenterol Hepatol       Date:  2017-01-28

4.  Artificial Intelligence Analysis of Celiac Disease Using an Autoimmune Discovery Transcriptomic Panel Highlighted Pathogenic Genes including BTLA.

Authors:  Joaquim Carreras
Journal:  Healthcare (Basel)       Date:  2022-08-16

5.  Distinct Role of IL-27 in Immature and LPS-Induced Mature Dendritic Cell-Mediated Development of CD4+ CD127+3G11+ Regulatory T Cell Subset.

Authors:  Fang Zhou; Guang-Xian Zhang; Abdolmohamad Rostami
Journal:  Front Immunol       Date:  2018-11-13       Impact factor: 7.561

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.